Memphasys (ASX:MEM) has increased the contract value of its five-year Master Commercial Distribution agreement with Doha-based International Technical Legacy for its Felix device to AU$390,000 from AU$325,000, and expanded it to include Turkey, according to a Thursday filing with the Australian bourse.